These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12010962

  • 1. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.
    Pang AL, Hashimoto CN, Tam LQ, Meng ZQ, Hui GS, Ho WK.
    Infect Immun; 2002 Jun; 70(6):2772-9. PubMed ID: 12010962
    [Abstract] [Full Text] [Related]

  • 2. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
    Leung WH, Meng ZQ, Hui G, Ho WK.
    Biochim Biophys Acta; 2004 Nov 18; 1675(1-3):62-70. PubMed ID: 15535968
    [Abstract] [Full Text] [Related]

  • 3. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
    Chang SP, Case SE, Gosnell WL, Hashimoto A, Kramer KJ, Tam LQ, Hashiro CQ, Nikaido CM, Gibson HL, Lee-Ng CT, Barr PJ, Yokota BT, Hut GS.
    Infect Immun; 1996 Jan 18; 64(1):253-61. PubMed ID: 8557348
    [Abstract] [Full Text] [Related]

  • 4. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.
    Hui GS, Hashiro C, Nikaido C, Case SE, Hashimoto A, Gibson H, Barr PJ, Chang SP.
    Infect Immun; 1993 Aug 18; 61(8):3403-11. PubMed ID: 7687586
    [Abstract] [Full Text] [Related]

  • 5. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
    Mazumdar S, Mukherjee P, Yazdani SS, Jain SK, Mohmmed A, Chauhan VS.
    Infect Immun; 2010 Feb 18; 78(2):872-83. PubMed ID: 19933832
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 7. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
    Gupta PK, Mukherjee P, Dhawan S, Pandey AK, Mazumdar S, Gaur D, Jain SK, Chauhan VS.
    Clin Vaccine Immunol; 2014 Jun 15; 21(6):886-97. PubMed ID: 24789797
    [Abstract] [Full Text] [Related]

  • 8. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
    Faber BW, Remarque EJ, Morgan WD, Kocken CH, Holder AA, Thomas AW.
    Infect Immun; 2007 Dec 15; 75(12):5947-55. PubMed ID: 17938224
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
    Pan W, Ravot E, Tolle R, Frank R, Mosbach R, Türbachova I, Bujard H.
    Nucleic Acids Res; 1999 Feb 15; 27(4):1094-103. PubMed ID: 9927744
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
    Hui GS, Nikaido C, Hashiro C, Kaslow DC, Collins WE.
    Infect Immun; 1996 May 15; 64(5):1502-9. PubMed ID: 8613353
    [Abstract] [Full Text] [Related]

  • 15. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H.
    Malar J; 2010 Mar 18; 9():77. PubMed ID: 20298576
    [Abstract] [Full Text] [Related]

  • 16. Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
    Wu S, Beier M, Sztein MB, Galen J, Pickett T, Holder AA, Gómez-Duarte OG, Levine MM.
    J Biotechnol; 2000 Sep 29; 83(1-2):125-35. PubMed ID: 11000468
    [Abstract] [Full Text] [Related]

  • 17. Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.
    Arnot DE, Cavanagh DR, Remarque EJ, Creasey AM, Sowa MP, Morgan WD, Holder AA, Longacre S, Thomas AW.
    Clin Vaccine Immunol; 2008 Sep 29; 15(9):1345-55. PubMed ID: 18550731
    [Abstract] [Full Text] [Related]

  • 18. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A, Coulibaly B, Remarque EJ, Bujard H, Epp C.
    Clin Vaccine Immunol; 2017 Nov 29; 24(11):. PubMed ID: 28877929
    [Abstract] [Full Text] [Related]

  • 19. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
    Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS.
    Infect Immun; 2004 Oct 29; 72(10):5775-82. PubMed ID: 15385477
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.
    Keitel WA, Kester KE, Atmar RL, White AC, Bond NH, Holland CA, Krzych U, Palmer DR, Egan A, Diggs C, Ballou WR, Hall BF, Kaslow D.
    Vaccine; 1999 Oct 14; 18(5-6):531-9. PubMed ID: 10519944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.